Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00114816 |
|---|---|
| Brief Title: | Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer |
| First Submitted : | June 17, 2005 |
| First Submitted that Met QC Criteria : | June 17, 2005 |
| First Posted : | June 20, 2005 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 18, 2007 |
| Last Update Posted : | May 21, 2007 (Estimate) |